Researchers at Johns Hopkins are promoting the transition of flu vaccines to the mRNA platform, which can be manufactured in 100 days without using chicken eggs. This shift is presented as a way to better match circulating strains like H3N3. Additionally, a senior-specific vaccine called Flu Block is being produced using insect cells rather than traditional egg-based methods.
